检验医学 ›› 2021, Vol. 36 ›› Issue (7): 756-760.DOI: 10.3969/j.issn.1673-8640.2021.07.017
收稿日期:
2019-11-01
出版日期:
2021-07-30
发布日期:
2021-07-26
通讯作者:
项明洁
作者简介:
项明洁,E-mail: mjxiang123456@126.com。基金资助:
LIU Jinyan, ZHAO Juntao, XIANG Mingjie()
Received:
2019-11-01
Online:
2021-07-30
Published:
2021-07-26
Contact:
XIANG Mingjie
摘要:
血清淀粉样蛋白A(SAA)属于急性时相反应蛋白,在感染急性期、炎症反应、组织损伤时迅速升高,在恢复期迅速下降。SAA与细菌或病毒感染、动脉粥样硬化、肿瘤、移植排斥反应、类风湿性关节炎、淀粉样病变等密切相关。文章主要就淀粉样蛋白(AA)超家族的结构、功能、检测方法及SAA在各种疾病中的作用机制及应用进展作一综述。
中图分类号:
刘锦燕, 赵珺涛, 项明洁. 血清淀粉样蛋白A在疾病中的作用机制及应用研究进展[J]. 检验医学, 2021, 36(7): 756-760.
LIU Jinyan, ZHAO Juntao, XIANG Mingjie. Mechanism and application of serum amyloid A in clinical diseases[J]. Laboratory Medicine, 2021, 36(7): 756-760.
[1] |
SHRIDAS P, DE BEER M C, WEBB N R. High-density lipoprotein inhibits serum amyloid A-mediated reactive-oxygen species generation and NLRP3 inflammasome activation[J]. J Biol Chem, 2018, 293(34):13257-13269.
DOI URL |
[2] |
DE BUCK M, GOUWY M, WANG J M, et al. Structure and expression of different serum amyloid A(SAA) variants and their concentration-dependent functions during host insults[J]. Curr Med Chem, 2016, 23(17):1725-1755.
DOI URL |
[3] |
UHLAR C M, WHITEHEAD A S. Serum amyloid A,the major vertebrate acute-phase reactant[J]. Eur J Biochem, 1999, 265(2):501-523.
DOI URL |
[4] | 陈长强, 顾志冬, 樊绮诗. 血清淀粉样蛋白A在疾病应用中的研究进展[J]. 检验医学, 2012, 27(9):776-779. |
[5] |
KLUVE-BECKERMAN B, YAMADA T, HARDWICK J, et al. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2[J]. Biochem J, 1997, 322(Pt2):663-669.
DOI URL |
[6] | GRIFFITHS K, PAZDERSKA A, AHMED M, et al. Type 2 diabetes in young females results in increased serum amyloid a and changes to features of high density lipoproteins in both HDL2,and HDL3[J]. J Diabetes Res, 2017, 2017:1314864. |
[7] |
THOMPSON J C, WILSON P G, SHRIDAS P, et al. Serum amyloid A3 is pro-atherogenic[J]. Atherosclerosis, 2018, 268:32-35.
DOI URL |
[8] |
AZURMENDI L, LAPIERREFETAUD V, SCHNEIDER J, et al. Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection:a pilot study[J]. Clin Proteomics, 2017, 14(1):27.
DOI URL |
[9] |
THOMPSON J C, JAYNE C, THOMPSON J, et al. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis[J]. J Lipid Res, 2015, 56(2):286-293.
DOI URL |
[10] | TAKASE H, FURUCHI H, TANAKA M, et al. Characterization of reconstituted high-density lipoprotein particles formed by lipid interactions with human serum amyloid A[J]. Biochim Biophys Acta, 2014, 1842:1467-1474. |
[11] |
HAN C Y, TANG C, GUEVARA M E, et al. Serum amyloid A impairs the anti-inflammatory properties of HDL[J]. J Clin Invest, 2016, 126(1):266-281.
DOI URL |
[12] |
TOMITA T, IEGUCHI K, SAWAMURA T, et al. Human serum amyloid A3(SAA3) protein,expressed as a fusion protein with SAA2,binds the oxidized low density lipoprotein receptor[J]. PLoS One, 2015, 10(3):e0118835.
DOI URL |
[13] | 陈振华, 蔡甜, 唐波, 等. 血清淀粉样蛋白A量子点免疫层析全血定量检测试剂的制备及性能评价[J]. 药物生物技术, 2018, 25(04):21-24. |
[14] | 姜剑巍, 杨宇, 应春妹. 乳胶增强免疫散射比浊法检测血清淀粉样蛋白A的应用评价[J]. 检验医学, 2015, 30(1):49-52. |
[15] | 陈长强, 杨晶, 顾志冬, 等. 斑点免疫金渗滤法定量测定血清淀粉样蛋白A方法的建立及性能评估[J]. 检验医学, 2013, 28(9):835-840. |
[16] | 李启欣, 梁指荣, 汤永平, 等. 血清淀粉样蛋白A免疫荧光层析法的建立[J]. 热带医学杂志, 2017, 17(9):1152-1155. |
[17] |
FLORES R J, KELLY A J, LI Y, et al. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma[J]. Pediatric Blood Cancer, 2017, 64(12):e26659.
DOI URL |
[18] | 田月如, 李巍, 叶志成, 等. 血清淀粉样蛋白A和C反应蛋白检测在儿童感染性疾病诊断中的应用[J]. 检验医学, 2017, 32(5):382-385. |
[19] |
AHOUT I M L, BRAND K H, ZOMER A, et al. Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children[J]. BMJ Open, 2017, 7(6):e014596.
DOI URL |
[20] | 李福刚, 雷蕾, 石晓强, 等. 血清淀粉样蛋白A(SAA)水平检测在临床实验诊断及健康监测中的应用[J]. 现代检验医学杂志, 2019,(3):1-5. |
[21] |
XIE X, MA Y T, YANG Y N, et al. Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk[J]. Tissue Antigens, 2015, 85(3):168-176.
DOI URL |
[22] | VAISAR T, HIPPE D, NERADILEK M, et al. HDL-associated serum amyloid A(SAA) may be a predictor of cardiovascular risk independent of HDL- or LDL-cholesterol[J]. Atherosclerosis, 2017, 263:e218. |
[23] | 王旋, 程龙献, 崔天盆, 等. 血清淀粉样蛋白A与冠心病及冠心病危险因素的关系[J]. 临床心血管病杂志, 2004, 20(12):745-747. |
[24] |
JOHNSON B D, KIP K E, MARROQUIN O C, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women:the National Heart,Lung,and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation(WISE)[J]. Circulation, 2004, 109(6):726-732.
DOI URL |
[25] |
ZHANG G, HARA H, YAMAMOTO T, et al. Serum amyloid a as an indicator of impending xenograft failure:experimental studies[J]. Int J Surg, 2018, 60:283-290.
DOI URL |
[26] |
ZAIRIS M N, ADAMOPOULOU E N, MANOUSAKIS S J, et al. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes[J]. Atherosclerosis, 2007, 194(2):397-402.
DOI URL |
[27] | 盛秀芝, 蔡溢, 周杰. 血清淀粉样蛋白A在肾移植术后排斥反应诊断中的价值[J]. 中国实验诊断学, 2010, 14(002):242-243. |
[28] |
WESTERMARK G T, FÄNDRICH M, WESTERMARK P. AA amyloidosis:pathogenesis and targeted therapy[J]. Annu Rev Pathol, 2015, 10:321-344.
DOI URL |
[29] |
JAYARAMAN S, GANTZ D L, HAUPT C, et al. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis[J]. Proc Natl Acad Sci U S A, 2017, 114(32):E6507-E6515.
DOI URL |
[30] | 余红梅, 周新, 彭志宇, 等. 血清淀粉样蛋白A1基因多态性与类风湿关节炎淀粉样变性的关系[J]. 新乡医学院学报, 2009, 26(1):46-49. |
[31] | 项国谦, 陈岳明, 冯迪英, 等. 血清淀粉样蛋白A在类风湿性关节炎中的临床价值[J]. 中国卫生检验杂志, 2016(20):2945-2946. |
[32] |
LIN H Y, TAN G Q, LIU Y, et al. The prognostic value of serum amyloid A in solid tumors:a meta-analysis[J]. Cancer Cell Int, 2019, 19(1):62.
DOI URL |
[33] |
DJUREC M, GRAÑA O, LEE A, et al. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors[J]. Proc Natl Acad Sci U S A, 2018, 115(6):E1147-E1156.
DOI URL |
[34] |
COOK M B, BARNETT M J, BOCK C H, et al. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma:a study within the National Cancer Institute Cohort Consortium[J]. Gut, 2019, 68(6):960-968.
DOI URL |
[35] |
ZHOU J, SHENG J, FAN Y, et al. Association between serum amyloid A levels and cancers:a systematic review and meta-analysis[J]. Postgrad Med J, 2018, 94(1115):499-507.
DOI URL |
[36] |
NG C T, YIP G W C, CHEN E S, et al. Gold nanoparticles induce serum amyloid A 1-Toll-like receptor 2 mediated NF-κB signaling in lung cellsin vitro[J]. Chem Biol Interact, 2018, 289:81-89.
DOI URL |
[37] |
RAMANKULOV A, LEIN M, JOHANNSEN M, et al. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma[J]. Cancer Lett, 2008, 269(1):85-92.
DOI URL |
[38] | 罗健青, 陈秀芳, 管敏昌, 等. 血常规、C-反应蛋白联合血清淀粉样蛋白A水平早期检测在儿童流感中的应用价值[J]. 中国卫生检验杂志, 2019, 29(4):432-434. |
[39] | 张慧, 陈皓. 支原体肺炎患儿的血清淀粉样蛋白A及人软骨糖蛋白-39水平变化与及预后的相关性分析[J]. 中国儿童保健杂志, 2019, 27(3):314-316. |
[40] | 赵学芹, 梁绮华, 黄家良, 等. 血清淀粉样蛋白A与C反应蛋白在小儿手足口病早期诊断中的临床应用价值[J]. 国际检验医学杂志, 2015, 36(18):2699-2701. |
[41] |
LU W, CHEN B, WANG C, et al. Serum amyloid A levels in acute and chronic urticaria[J]. An Bras Dermatol, 2019, 94(4):411-415.
DOI URL |
[42] | 孙娜, 冯冰瑜, 卢松科. C反应蛋白、血清淀粉样蛋白A联合Toll样受体蛋白4检测在儿童肾病中的表达变化及相关性研究[J]. 中国中西医结合肾病杂志, 2019, 20(5):421-423. |
[43] | 冯烨, 张宇, 周娟, 等. 血清淀粉样蛋白A水平在幼年特发性关节炎疾病活动度评估中的价值分析[J]. 第三军医大学学报, 2017, 39(19):1933-1938. |
[1] | 周韵斓, 沈立松. 液体活检标志物在非小细胞肺癌中的临床应用和挑战[J]. 检验医学, 2023, 38(9): 807-811. |
[2] | 王杨淑怡, 叶威, 林志豪, 黄约诺, 方涛, 董晓亭. 肺腺癌焦亡相关特征模型的构建和验证[J]. 检验医学, 2023, 38(9): 833-841. |
[3] | 彭伟, 李运改, 许静, 刘华, 杨翠霞, 沈云岳. 血清炎症因子联合PSA、f-PSA可辅助诊断前列腺癌[J]. 检验医学, 2023, 38(9): 849-854. |
[4] | 王慧英, 汤昱, 董利利, 王静. 肺炎支原体RNA检测用于肺炎患儿疾病诊断和疗效监测[J]. 检验医学, 2023, 38(9): 865-869. |
[5] | 卫明珠, 潘继文, 罗锐, 陈俊辉. 凝血4项和肿瘤标志物对乙型肝炎相关肝癌的辅助诊断价值[J]. 检验医学, 2023, 38(9): 901-904. |
[6] | 赵静, 李永勤, 李艳, 范伟光, 杨学刚. HIV/AIDS合并机会性感染患者IP-10、SAA、hs-CRP、PCT、CD4+ T细胞计数检测的意义[J]. 检验医学, 2023, 38(8): 725-729. |
[7] | 丁肖媛, 戴劲盛, 焦荣红, 马素丽, 朱海峰, 吴梦雅, 车艳然, 张蕾. 肥胖/超重对哮喘发作期患儿Th1/Th2和Th17/Treg细胞因子的影响[J]. 检验医学, 2023, 38(8): 748-752. |
[8] | 张娜, 牛伟华, 孙媛媛, 贾玫. CMV和EBV共感染可影响造血干细胞移植患者预后[J]. 检验医学, 2023, 38(8): 760-765. |
[9] | 王朝, 赵煜. 持留菌形成机制和清除策略研究进展[J]. 检验医学, 2023, 38(8): 790-795. |
[10] | 马建国, 李洪春. 冠心病患者血脂水平与心功能指标的相关性[J]. 检验医学, 2023, 38(7): 659-664. |
[11] | 王腾飞, 陈珊, 安和兵, 周蕾. 急性白血病患者外周血lncRNA CRNDE、miR-384表达及其临床意义[J]. 检验医学, 2023, 38(7): 686-691. |
[12] | 刘亚楠, 夏敏, 胡韶华, 郑月, 张泓. 淋巴细胞亚群、炎症因子和氨基末端B型钠尿肽原联合检测诊断川崎病[J]. 检验医学, 2023, 38(6): 532-537. |
[13] | 乌有弘, 宋云霄, 朱勇, 葛雯, 卞晓波, 袁文华, 赵智赟. 血脂水平在冠心病患者冠状动脉狭窄评估和治疗中的价值[J]. 检验医学, 2023, 38(6): 584-589. |
[14] | 赵婧, 王佩, 卢丹丹, 齐丹丹, 李轩. 出血性脑卒中患者血清miR-4443、TRAF4相对表达量变化的临床意义[J]. 检验医学, 2023, 38(5): 413-418. |
[15] | 高锋. 新型肿瘤标志物的临床应用——前景与挑战[J]. 检验医学, 2023, 38(4): 303-306. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||